229 related articles for article (PubMed ID: 31083564)
1. The Cross-Talk Between the TNF-α and RASSF-Hippo Signalling Pathways.
Oceandy D; Amanda B; Ashari FY; Faizah Z; Azis MA; Stafford N
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31083564
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressor ras association domain family 5 (RASSF5/NORE1) mediates death receptor ligand-induced apoptosis.
Park J; Kang SI; Lee SY; Zhang XF; Kim MS; Beers LF; Lim DS; Avruch J; Kim HS; Lee SB
J Biol Chem; 2010 Nov; 285(45):35029-38. PubMed ID: 20810663
[TBL] [Abstract][Full Text] [Related]
3. Hippo pathway-dependent and -independent roles of RASSF6.
Ikeda M; Kawata A; Nishikawa M; Tateishi Y; Yamaguchi M; Nakagawa K; Hirabayashi S; Bao Y; Hidaka S; Hirata Y; Hata Y
Sci Signal; 2009 Sep; 2(90):ra59. PubMed ID: 19797269
[TBL] [Abstract][Full Text] [Related]
4. RASSF effectors couple diverse RAS subfamily GTPases to the Hippo pathway.
Dhanaraman T; Singh S; Killoran RC; Singh A; Xu X; Shifman JM; Smith MJ
Sci Signal; 2020 Oct; 13(653):. PubMed ID: 33051258
[TBL] [Abstract][Full Text] [Related]
5. Lgl, aPKC, and Crumbs regulate the Salvador/Warts/Hippo pathway through two distinct mechanisms.
Grzeschik NA; Parsons LM; Allott ML; Harvey KF; Richardson HE
Curr Biol; 2010 Apr; 20(7):573-81. PubMed ID: 20362447
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppressor C-RASSF proteins.
Iwasa H; Hossain S; Hata Y
Cell Mol Life Sci; 2018 May; 75(10):1773-1787. PubMed ID: 29353317
[TBL] [Abstract][Full Text] [Related]
7. Rheb may complex with RASSF1A to coordinate Hippo and TOR signaling.
Nelson N; Clark GJ
Oncotarget; 2016 Jun; 7(23):33821-31. PubMed ID: 27034171
[TBL] [Abstract][Full Text] [Related]
8. The Hippo Pathway: Biology and Pathophysiology.
Ma S; Meng Z; Chen R; Guan KL
Annu Rev Biochem; 2019 Jun; 88():577-604. PubMed ID: 30566373
[TBL] [Abstract][Full Text] [Related]
9. Ras signaling through RASSF proteins.
Donninger H; Schmidt ML; Mezzanotte J; Barnoud T; Clark GJ
Semin Cell Dev Biol; 2016 Oct; 58():86-95. PubMed ID: 27288568
[TBL] [Abstract][Full Text] [Related]
10. The tumour suppressor Ras-association domain family protein 1A (RASSF1A) regulates TNF-α signalling in cardiomyocytes.
Mohamed TM; Zi M; Prehar S; Maqsood A; Abou-Leisa R; Nguyen L; Pfeifer GP; Cartwright EJ; Neyses L; Oceandy D
Cardiovasc Res; 2014 Jul; 103(1):47-59. PubMed ID: 24776599
[TBL] [Abstract][Full Text] [Related]
11. Filling out the Hippo pathway.
Saucedo LJ; Edgar BA
Nat Rev Mol Cell Biol; 2007 Aug; 8(8):613-21. PubMed ID: 17622252
[TBL] [Abstract][Full Text] [Related]
12. Ras-association domain family protein 6 induces apoptosis via both caspase-dependent and caspase-independent pathways.
Ikeda M; Hirabayashi S; Fujiwara N; Mori H; Kawata A; Iida J; Bao Y; Sato Y; Iida T; Sugimura H; Hata Y
Exp Cell Res; 2007 Apr; 313(7):1484-95. PubMed ID: 17367779
[TBL] [Abstract][Full Text] [Related]
13. WW domain interactions regulate the Hippo tumor suppressor pathway.
Salah Z; Aqeilan RI
Cell Death Dis; 2011 Jun; 2(6):e172. PubMed ID: 21677687
[TBL] [Abstract][Full Text] [Related]
14. Hippo pathway - brief overview of its relevance in cancer.
Zygulska AL; Krzemieniecki K; Pierzchalski P
J Physiol Pharmacol; 2017 Jun; 68(3):311-335. PubMed ID: 28820389
[TBL] [Abstract][Full Text] [Related]
15. Structural insight into dimeric interaction of the SARAH domains from Mst1 and RASSF family proteins in the apoptosis pathway.
Hwang E; Ryu KS; Pääkkönen K; Güntert P; Cheong HK; Lim DS; Lee JO; Jeon YH; Cheong C
Proc Natl Acad Sci U S A; 2007 May; 104(22):9236-41. PubMed ID: 17517604
[TBL] [Abstract][Full Text] [Related]
16. Emerging role of Hippo signalling pathway in bladder cancer.
Xia J; Zeng M; Zhu H; Chen X; Weng Z; Li S
J Cell Mol Med; 2018 Jan; 22(1):4-15. PubMed ID: 28782275
[TBL] [Abstract][Full Text] [Related]
17. Disease implication of hyper-Hippo signalling.
Wang SP; Wang LH
Open Biol; 2016 Oct; 6(10):. PubMed ID: 27805903
[TBL] [Abstract][Full Text] [Related]
18. Promoter Hypermethylation of Genes Encoding for RASSF/Hippo Pathway Members Reveals Specific Alteration Pattern in Diffuse Gliomas.
Levallet G; Creveuil C; Bekaert L; Péres E; Planchard G; Lecot-Cotigny S; Guillamo JS; Emery E; Zalcman G; Lechapt-Zalcman E
J Mol Diagn; 2019 Jul; 21(4):695-704. PubMed ID: 31055025
[TBL] [Abstract][Full Text] [Related]
19. The bantam microRNA is a target of the hippo tumor-suppressor pathway.
Nolo R; Morrison CM; Tao C; Zhang X; Halder G
Curr Biol; 2006 Oct; 16(19):1895-904. PubMed ID: 16949821
[TBL] [Abstract][Full Text] [Related]
20. Targeting the Hippo signalling pathway for cancer treatment.
Nakatani K; Maehama T; Nishio M; Goto H; Kato W; Omori H; Miyachi Y; Togashi H; Shimono Y; Suzuki A
J Biochem; 2017 Mar; 161(3):237-244. PubMed ID: 28003431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
